Saliva test for endometriosis: will it improve Women's lives?

NCT ID NCT07560852

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 20,000 women who take a new saliva test (Endotest) to diagnose endometriosis. Researchers want to see how the test result—positive or negative—affects their quality of life, emotions, and care decisions. Participants fill out questionnaires and share medical data over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Saint Etienne

    NOT_YET_RECRUITING

    Saint-Priest-en-Jarez, Pays de la Loire Region, 42270, France

  • Centre Hospitalier de Pau

    NOT_YET_RECRUITING

    Pau, Pyrénées Atlantiques, 64000, France

  • Clinique Tivoli Ducos

    RECRUITING

    Bordeaux, Gironde, 33000, France

  • Groupe Hospitalier Bretagne Sud - GHBS - Lorient

    NOT_YET_RECRUITING

    Lorient, Morbihan, 56100, France

  • Hôpital Jacques Monod - GH du Havre

    NOT_YET_RECRUITING

    Montivilliers, Seine-maritime, 76290, France

  • Hôpital de Mercy - CHR Metz Thionville

    NOT_YET_RECRUITING

    Peltre, Moselle, 57245, France

  • Hôpital privé Saint-Grégoire

    NOT_YET_RECRUITING

    Saint-Grégoire, Ille-et-Vilaine, 35760, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.